✦ LIBER ✦

Process Development of CP-481715, a Novel CCR1 Antagonist

✍ Scribed by Li, Bryan; Andresen, Brian; Brown, Matthew F.; Buzon, Richard A.; Chiu, Charles K.-F.; Couturier, Michel; Dias, Eric; Urban, Frank J.; Jasys, V. John; Kath, John C.; Kissel, William; Le, Tung; Li, Z. Jane; Negri, Joanna; Poss, Christopher S.; Tucker, John; Whritenour, David; Zandi, Kathleen

Book ID: 126939824
Publisher: American Chemical Society
Year: 2005
Tongue: English
Weight: 102 KB
Volume: 9
Category: Article
ISSN: 1083-6160
DOI: 10.1021/op050059w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of the effect of the specific

Evaluation of the effect of the specific CCR1 antagonist CP-481715 on the clinical and cellular responses observed following epicutaneous nickel challenge in human subjects

✍ Jeanett Borregaard; Lone Skov; Lisy Wang; Naitee Ting; Cunshan Wang; Lisa A. Bec 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Process Development of a Novel Non-Xanth

Process Development of a Novel Non-Xanthine Adenosine A1 Receptor Antagonist

✍ Zanka, Atsuhiko; Uematsu, Ryoichi; Morinaga, Yasuhiro; Yasuda, Hironobu; Yamazak 📂 Article 📅 1999 🏛 American Chemical Society 🌐 English ⚖ 130 KB

Development of a Scalable Process for CI

Development of a Scalable Process for CI-1020, A Novel Endothelin Antagonist 1

✍ Ellis, James E.; Davis, Edward M.; Dozeman, Gary J.; Lenoir, Edward A.; Belmont, 📂 Article 📅 2001 🏛 American Chemical Society 🌐 English ⚖ 89 KB

Process Development of a Potent Bradykin

Process Development of a Potent Bradykinin 1 Antagonist

✍ Menzel, Karsten; Machrouhi, Fouzia; Bodenstein, Matthew; Alorati, Anthony; Cowde 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 250 KB

ChemInform Abstract: Process Development

ChemInform Abstract: Process Development of a Novel Non-xanthine Adenosine A1 Receptor Antagonist.

✍ Atsuhiko Zanka; Ryoichi Uematsu; Yasuhiro Morinaga; Hironobu Yasuda; Hiroshi Yam 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 32 KB 👁 2 views

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of TBR-652, a Novel CCR5 Antagonist, in HIV-1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naive Patients

✍ Marier, J.-F.; Trinh, M.; Pheng, L. H.; Palleja, S. M.; Martin, D. E. 📂 Article 📅 2011 🏛 American Society for Microbiology 🌐 English ⚖ 490 KB